Biomarker Assessment: Clinical Trials

3 trials of Biomarker Assessment, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 not yet recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Not yet recruiting 1

Follow Biomarker Assessment: new trials by email Literature Review of Biomarker Assessment trials Research Report on Biomarker Assessment

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multicenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality?
Early Cerebro-spinal MRI, Biomarker Assessment, Clinical and Neuropsychological Evaluations - Multiple Sclerosis, RRMS
Not applicableNot yet recruitingUniversity Hospital, Strasbourg, France1362026-09-012026-04-22
Assessment of Biomarkers in Patients With Decompensated Heart Failure and Underlying Coronary Artery Disease
Biomarker Assessment - Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease
CompletedCirQuest Labs, LLC942018-08-132026-10-20
The Hong Kong Diabetes Biobank
prospective observational study - Diabetes Mellitus, Type 2 Diabetes
Active not recruitingChinese University of Hong Kong480002014-02-012026-03-12

Conditions studied

Cardiovascular Diseases (1)  ·  Conversion Disorder (1)  ·  Coronary Artery Disease (1)  ·  Coronary Disease (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Diabetic Angiopathies (1)  ·  Diabetic Nephropathies (1)  ·  Diabetic Retinopathy (1)  ·  Multiple Sclerosis (1)  ·  Multiple Sclerosis, Relapsing-Remitting (1)  ·  Stroke (1)

Sponsors

Chinese University of Hong Kong (1)  ·  CirQuest Labs, LLC (1)  ·  University Hospital, Strasbourg, France (1)

Countries

France (1)  ·  Hong Kong (1)  ·  United States (1)

Top investigators

Lisa K. Jennings, PhD (1)  ·  Ronald C Ma, FRCP (1)